AttributesValues
rdf:type
Description
  • The MM-015 trial assessed lenalidomide-based therapy on health-related quality of life. Patients completed health-related quality of life questionnaires at baseline, after every third treatment cycle, and treatment end. Health-related quality of life improved in all treatment groups during induction therapy. More patients receiving lenalidomide maintenance achieved minimally important differences (P<0.05 for Physical Functioning). Therefore, lenalidomide, melphalan, and prednisone, followed by lenalidomide maintenance improves health-related quality of life in patients with newly diagnosed multiple myeloma.
  • The MM-015 trial assessed lenalidomide-based therapy on health-related quality of life. Patients completed health-related quality of life questionnaires at baseline, after every third treatment cycle, and treatment end. Health-related quality of life improved in all treatment groups during induction therapy. More patients receiving lenalidomide maintenance achieved minimally important differences (P<0.05 for Physical Functioning). Therefore, lenalidomide, melphalan, and prednisone, followed by lenalidomide maintenance improves health-related quality of life in patients with newly diagnosed multiple myeloma. (en)
Title
  • Lenalidomide, melphalan, and prednisone followed by lenalidomide maintenance improves health-related quality of life in newly diagnosed multiple myeloma patients aged 65 years or older: results of a randomized phase III trial
  • Lenalidomide, melphalan, and prednisone followed by lenalidomide maintenance improves health-related quality of life in newly diagnosed multiple myeloma patients aged 65 years or older: results of a randomized phase III trial (en)
skos:prefLabel
  • Lenalidomide, melphalan, and prednisone followed by lenalidomide maintenance improves health-related quality of life in newly diagnosed multiple myeloma patients aged 65 years or older: results of a randomized phase III trial
  • Lenalidomide, melphalan, and prednisone followed by lenalidomide maintenance improves health-related quality of life in newly diagnosed multiple myeloma patients aged 65 years or older: results of a randomized phase III trial (en)
skos:notation
  • RIV/61988987:17110/12:A13017JD!RIV13-MSM-17110___
http://linked.open...avai/predkladatel
http://linked.open...avai/riv/aktivita
http://linked.open...avai/riv/aktivity
  • I
http://linked.open...iv/cisloPeriodika
  • Dec 14
http://linked.open...vai/riv/dodaniDat
http://linked.open...aciTvurceVysledku
http://linked.open.../riv/druhVysledku
http://linked.open...iv/duvernostUdaju
http://linked.open...titaPredkladatele
http://linked.open...dnocenehoVysledku
  • 146810
http://linked.open...ai/riv/idVysledku
  • RIV/61988987:17110/12:A13017JD
http://linked.open...riv/jazykVysledku
http://linked.open.../riv/klicovaSlova
  • Health-related quality of life; multiple myeloma; lenalidomide; QLQ-C30; QLQ-MY20 (en)
http://linked.open.../riv/klicoveSlovo
http://linked.open...odStatuVydavatele
  • IT - Italská republika
http://linked.open...ontrolniKodProRIV
  • [922566B9600D]
http://linked.open...i/riv/nazevZdroje
  • Haematologica
http://linked.open...in/vavai/riv/obor
http://linked.open...ichTvurcuVysledku
http://linked.open...cetTvurcuVysledku
http://linked.open...UplatneniVysledku
http://linked.open...v/svazekPeriodika
  • 97
http://linked.open...iv/tvurceVysledku
  • Hájek, Roman
  • Zhang, J.
  • Dimopoulos, M. A.
  • Delforge, M.
  • Kropff, M.
  • Lewis, P.
  • Mei, J.
  • Nixon, A.
  • Palumbo, A.
  • Petrucci, MT
issn
  • 1592-8721
number of pages
http://localhost/t...ganizacniJednotka
  • 17110
is http://linked.open...avai/riv/vysledek of
Faceted Search & Find service v1.16.118 as of Jun 21 2024


Alternative Linked Data Documents: ODE     Content Formats:   [cxml] [csv]     RDF   [text] [turtle] [ld+json] [rdf+json] [rdf+xml]     ODATA   [atom+xml] [odata+json]     Microdata   [microdata+json] [html]    About   
This material is Open Knowledge   W3C Semantic Web Technology [RDF Data] Valid XHTML + RDFa
OpenLink Virtuoso version 07.20.3240 as of Jun 21 2024, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (126 GB total memory, 58 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software